Reproductive Health & Justice The Center for Reproductive Rights Submits Comment Opposing Baseless Environmental Claims to Restrict Mifepristone Access June 15, 2026 Rifan Muazin The Center for Reproductive Rights has formally submitted a comprehensive comment to the Food and Drug Administration (FDA), vehemently opposing three Citizen Petitions put forth by the anti-abortion organization Students…
Reproductive Health & Justice The Center for Reproductive Rights Challenges Baseless Environmental Claims Used to Restrict Mifepristone Access June 4, 2026 Rifan Muazin The Center for Reproductive Rights (CRR) has formally lodged a strong objection with the Food and Drug Administration (FDA), challenging three Citizen Petitions submitted by the anti-abortion organization Students for…
Reproductive Health & Justice Center for Reproductive Rights Opposes "Baseless Environmental Claims" Targeting Mifepristone Access May 27, 2026 Rifan Muazin The Center for Reproductive Rights has formally submitted a detailed comment to the Food and Drug Administration (FDA) vehemently opposing three Citizen Petitions filed by the anti-abortion organization Students for…
Reproductive Health & Justice Supreme Court Temporarily Halts In-Person Dispensing Requirement for Abortion Pill Mifepristone May 26, 2026 Rifan Muazin The U.S. Supreme Court has issued a temporary administrative stay, pausing a restrictive ruling by the Fifth Circuit Court of Appeals that would have mandated in-person dispensing of the abortion…
Reproductive Health & Justice Supreme Court Pauses Restrictions on Telehealth Access to Abortion Pill Mifepristone Amid Ongoing Legal Battles May 22, 2026 Rifan Muazin The U.S. Supreme Court has issued a critical order allowing individuals to continue accessing the abortion medication mifepristone through telehealth services and subsequent delivery via mail or pickup at local…
Reproductive Health & Justice Supreme Court Allows Telehealth Access to Mifepristone Amid Ongoing Legal Challenge May 15, 2026 Rifan Muazin The U.S. Supreme Court has issued a pivotal order ensuring that individuals can continue to access the abortion pill mifepristone through telehealth services and receive it via mail or at…
Reproductive Health & Justice Telehealth Abortion Care Access Jeopardized as Court Temporarily Reinstates In-Person Dispensing Requirement for Mifepristone May 2, 2026 Rifan Muazin The landscape of reproductive healthcare in the United States faces a significant disruption following a recent ruling by the 5th Circuit Court of Appeals, which has temporarily reinstated a requirement…
Reproductive Health & Justice FOIA Request Seeks Comprehensive Safety Data on Mifepristone from FDA April 24, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been formally submitted to the U.S. Food and Drug Administration (FDA), seeking a broad spectrum of safety data pertaining to mifepristone, a…
Reproductive Health & Justice Federal Lawmakers Mount Renewed Assault on Mifepristone Access Amidst Escalating State-Level Reproductive Rights Battles April 22, 2026 Rifan Muazin The landscape of reproductive rights in the United States is undergoing a profound and often turbulent transformation, marked by persistent federal legislative challenges and a wave of restrictive state-level actions.…
Reproductive Health & Justice FOIA Request Filed for Comprehensive Mifepristone Safety Data Amid Evolving Regulatory Scrutiny April 16, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on March 20, 2026, seeking a broad spectrum of safety data related to mifepristone, a medication widely used in medication abortion…
